Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion
about
Pathogenesis of human immunodeficiency virus infectionT lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE)Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionComplement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centersDifferential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunctionThe role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus.Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle SanctuaryInterference with complement regulatory molecules as a possible therapeutic strategy in HIV infection.Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDSIncreased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infectionEnhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1Human serum protein enhances HIV-1 replication and up-regulates the transcription factor AP-1.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21)."Marker of Self" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumorsComplement Protein C1q Interacts with DC-SIGN via Its Globular Domain and Thus May Interfere with HIV-1 Transmission.HIV-1 gp120: a novel viral B cell superantigen.Mechanisms by which HIV envelope minimizes immunogenicity.Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.Effects of Standardized Eriobotrya japonica Extract in LP-BM5 Murine Leukemia Viruses-Induced Murine Immunodeficiency Syndrome.A "complement-ary" AIDS vaccine.Complement-mediated enhancement of HIV-1 infection in peripheral blood mononuclear cells.Regulation of C3 deposition on gp120 coated CD4 positive cells by decay accelerating factor and factor H.Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV.Antibody mediated enhancement of HIV-1 infection of an EBV transformed B cell line is CD4 dependent.Mechanisms of opsonized HIV entry in normal B lymphocytes.Applications of the FIV Model to Study HIV Pathogenesis.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
P2860
Q24634681-10D956B0-AFF5-491B-8582-CE42C03E0525Q24672100-D234E35D-6CBC-4B04-AE1D-AD4640EB69A7Q24675546-29E3937A-2FD7-4ACD-8180-CD0B8AB3BD55Q27469507-81E22C82-13C6-48AB-BA94-7A77462F46B5Q27480895-B4D87525-5FC8-45BF-84D9-0FDDEE17B824Q28236758-7CAC648C-CC6D-4AF3-9E31-A74636D8D5E3Q33637951-D48C2BC8-D9CD-44C9-9824-079742E984E1Q33742139-957B998F-63E7-4353-A7A5-A6794DD712E0Q34074689-8610A0E9-1C7C-4AA0-9EA3-6A6BF34BECA6Q35165707-899CCE59-0C4D-4D38-B33B-2E339FEAC793Q35837798-15FB53C9-D65D-4CDA-A1DE-34A97FEADACCQ36230737-26395C48-F6EF-47EF-AD24-0D3B4D93F267Q36365174-83B5CB29-A47F-4C99-8F04-AD806AAC9DFCQ36378510-A8411240-0759-4167-9C96-90716074D605Q36645449-2D663373-07DE-414E-8334-6DAE444B7132Q37490583-9F4E145D-D827-4586-9DA6-361D6FF2F907Q37525426-86A2314C-E53A-4E9D-915E-417AEE103A4BQ38524329-B95B1B9A-10A6-48C4-8303-D06BEEEC7D77Q39619603-7D838D28-96BB-4F85-A7AD-8272AF6363D1Q40047494-C8DBF04B-5B6B-4688-96C4-D19CDA0BA911Q40056665-F866CCBD-2770-450A-A44B-96030CA17F76Q40119230-6F439DD8-9268-4333-8073-65C3DBBCA2BBQ40953980-245010AA-DFCE-470B-AE9A-0FBAE1AF0466Q41136731-E0901EA3-C0AC-43E0-BCB4-BD25337F28D0Q41425849-880FCEA5-35A1-4777-831B-3AC6E49D2541Q41536475-73985B14-F7D9-4CD4-95AA-57F8A2D807E0Q41593439-376D1BE4-CDC5-4AED-A36E-E9E74554D3FCQ41599750-9F04B7F7-3C6D-43D4-B1EC-5C7DC2DE1614Q43542038-6C84E126-5CA0-45B4-9582-1D4DF226730CQ52574472-A4923067-B06E-4B49-A5C6-1BF3C76FC20DQ53686365-8A67B366-3B74-4EA1-89FF-68E0D1D28680
P2860
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Complement mediates human immu ...... d antibody-independent fashion
@ast
Complement mediates human immu ...... d antibody-independent fashion
@en
type
label
Complement mediates human immu ...... d antibody-independent fashion
@ast
Complement mediates human immu ...... d antibody-independent fashion
@en
prefLabel
Complement mediates human immu ...... d antibody-independent fashion
@ast
Complement mediates human immu ...... d antibody-independent fashion
@en
P2093
P2860
P356
P1476
Complement mediates human immu ...... d antibody-independent fashion
@en
P2093
Desgranges C
Kazatchkine MD
Trabaud MA
P2860
P304
P356
10.1084/JEM.173.5.1151
P407
P577
1991-05-01T00:00:00Z